Riso Pharmaceuticals International

Bioadvantex

Urixin

Silexin

Biolyse

Paclitaxel

BioSyent Inc.

FeraMAX

Feldan

Glenwood

Helsinn

Gelclair

Klean-Prep

Nasaleze Ltd.

Nasaleze

Omega laboratories

Pamidronate

PISA

Serral Laboratories

Stella Pharmaceutical Canada Inc.

Kolik-Gripe Water

Unigene

Fortical

Nasaleze

nasaleze
Natural prevention of allergy symptoms from hay fever, dust mites and animal dander.

One-a-day application
Natural and safe
Drug free
Non habit forming
Works in minutes
Non drowsy
Safe for pregnant women
Safe for children
Upto 30-day supply (200 doses)

Riso Pharma Tech is a Canadian-based specialty pharmaceutical company focused on in-licensing late-stage and approved molecules for marketing and sales in Canada, certain European Union countries, Latin America, and the Middle East.

From large multi-national pharmaceutical companies to small biotechs, Riso's license deals have yielded successful product launches in its territories. Five regional offices and over 360 employees worldwide enable Riso to extend the reach of our partner companies' products.

With an extensive track record of greater than 10+ years marketing and sales success in its territories, and thanks to Riso's financial strength, Riso is aggressively pursuing new in-licensing opportunities across several therapeutic areas: oncology, supportive care, neurology, endocrinology and women's health.